Filter
890
Text search:
adverse
drug
reactions
Featured
Recommendations
116
New Publications
260
Language
Document type
No document type
585
Guidelines
144
Studies & Reports
79
Manuals
42
Strategic & Response Plan
13
Fact sheets
11
Training Material
9
Situation Updates
3
Brochures
2
Resource Platforms
1
Infographics
1
Countries / Regions
India
68
Kenya
28
South Africa
27
Ethiopia
26
Tanzania
22
Western and Central Europe
21
Uganda
19
Nigeria
17
Zambia
17
Global
17
Malawi
16
Nepal
15
Ghana
14
Philippines
10
Cambodia
10
Bangladesh
10
Latin America and the Carribbean
10
Eastern Europe
10
Sierra Leone
9
Zimbabwe
9
Liberia
8
Namibia
8
Myanmar / Burma
8
Africa
8
USA
6
Rwanda
6
Botswana
6
Eswatini/ Swaziland
5
South–East Asia Region
5
South Sudan
3
Germany
3
Syria
3
Indonesia
3
Brazil
3
Ukraine
3
Western Pacific Region
3
Congo, Democratic Republic of
2
Haiti
2
Thailand
2
Argentina
2
Colombia
2
Bolivia
2
Lesotho
2
Sri Lanka
2
Asia
2
Timor Leste/ East Timor
2
Russia
2
Cameroon
1
Iraq
1
Lebanon
1
Gambia
1
China
1
Ireland
1
Mozambique
1
Benin
1
Angola
1
West and Central Africa
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Fiji
1
Solomon Islands
1
Bhutan
1
North Korea
1
Laos
1
Australia
1
Georgia
1
Vietnam
1
North America
1
Authors & Publishers
Publication Years
Category
Countries
351
Clinical Guidelines
136
Public Health
43
Women & Child Health
26
Capacity Building
15
Key Resources
12
Pharmacy & Technologies
11
Toolboxes
TB
130
Mental Health
78
HIV
69
Pharmacy
66
COVID-19
35
NTDs
34
AMR
27
Ebola
18
Caregiver
17
NCDs
14
Rapid Response
12
Refugee
10
Polio
8
Conflict
8
Specific Hazards
5
Cholera
4
Natural Hazards
4
Planetary Health
4
Disability
3
Zika
3
Global Health Education
3
Health Financing Toolbox
1
In many countries neonatal tetanus is responsible for half of all neonatal deaths due to vaccine-preventable diseases and for almost 14% of al¡ infant deaths. It is estimated that in the 1970s more than 10,000 newborns died annually from neonatal tetanus in the Americas. Neonatal tetanus is prevent
...
First Global Patient Safety Challenge Clean Care is Safer Care
The WHO Guidelines on Hand Hygiene in Health Care provide health-care workers (HCWs), hospital administrators and health authorities with a thorough review of evidence on hand hygiene in health care and specific recommendations to impro
...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these
...
A Global Campaign Against Epilepsy Demonstration Project
Guidance for health workers
2nd edition.
Like the original, this second edition of the guidance aims to inform the revision of existing national guidelines and standards for managing Tuberculosis (TB), many of which include guidance on children. It includes recommendations, based on the best available evidence, for improving
...
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information
...
The Access to Controlled Medications Programme identified the development of treatment guidelines that cover the treatment of all types of pain as one of the core areas of focus for improving access to opioid analgesics. Such guidelines are interesting both for health-care professionals and policy-
...
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim of the document is to assist Member States and releva
...
Towards the Peoples Health Assembly Book - 5
